Therefore, it was speculated that miR-27b inhibits the proliferation and promotes the apoptosis of DLBCL cells by targeting the expression of MET and inhibiting the activation of MET/PI3K/AKT pathway. Here, MET is linked to diffuse large B-cell lymphoma.